Submitting a Certified Copy of the Importing Country's Notification
An eligible country seeking to import a
patented drug or medical device under Canada's Access to Medicine's Regime must submit a
notification of its intentions, either to the
World Trade Organization (WTO), if it is a member, or to the Government of Canada, if it is not a WTO member.
The notification should declare that the product is not patented in the importing country or, if it is
patented, that the country will grant a compulsory
licence. The pharmaceutical company must include in its application package a certified copy of all
notifications submitted by the importing country.
|
